| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 9.735 | 20.349 | 49.539 | 18.439 |
| Total Income - EUR | - | - | - | - | - | - | 9.735 | 20.349 | 49.539 | 18.439 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 587 | 11.204 | 9.237 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 9.735 | 19.762 | 38.335 | 9.203 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 9.443 | 19.302 | 37.851 | 9.040 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Nextgen Pharma Trading S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 25 | 25 | 25 | 25 |
| Current Assets | - | - | - | - | - | - | 9.775 | 19.609 | 58.217 | 13.817 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 17.486 | 56.053 | 11.477 |
| Cash | - | - | - | - | - | - | 9.775 | 2.124 | 2.163 | 2.340 |
| Shareholders Funds | - | - | - | - | - | - | 9.483 | 19.366 | 57.157 | 9.089 |
| Social Capital | - | - | - | - | - | - | 0 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 317 | 269 | 1.084 | 4.753 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Nextgen Pharma Trading S.r.l.